General Information of Drug (ID: DM0ZDL3)

Drug Name
US9475795, 80 Drug Info
Synonyms SCHEMBL15548679; CHEMBL3891242; RXIULEDXXPGKEE-UHFFFAOYSA-N; BDBM250601; US9475795, 80; 4-(4-Chloro-2-fluorobenzyl)-1-((3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl)-4-fluoropiperidine
Cross-matching ID
PubChem CID
72550891
TTD Drug ID
DM0ZDL3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ZINC19658740 DMLZDAK N. A. N. A. Patented [2]
US9475795, 89 DMR6ODL N. A. N. A. Patented [1]
US9475795, 19 DMGPDEF N. A. N. A. Patented [1]
triazine compound PC10 DMCLA2D Discovery agent N.A. Investigative [3]
IS1 DMNF70P Discovery agent N.A. Investigative [4]
IS20 DMQ5GA9 Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Prokineticin receptor-1 (PROKR1) TTB9CIL PKR1_HUMAN Inhibitor [1]

References

1 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases. US9475795.
2 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases. US10167273.
3 Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain. J Nucl Med. 2011 Apr;52(4):600-7.
4 Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1. PLoS One. 2015 Apr 1;10(4):e0121027.